Bergman Alan B. bought AIDX
April 2, 2026 · Form 4 insider transaction
Bergman Alan B. bought 100,000 shares of 20/20 Biolabs, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,000
Price
$0.00
Total value
N/A
InsiderBergman Alan B.
Role—
Company20/20 Biolabs, Inc. (AIDX)
SecurityStock Option
Transaction codeA: Grant or award
Transaction dateApril 2, 2026
Filing dateApril 6, 2026
Shares owned after100,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25,000 of the shares subject to the stock option will vest on the first anniversary of the date of grant and the remaining shares will vest in equal monthly installments over the following 36 months, subject to the Reporting Person's continuous service to the Issuer.